|
Post by wsb36 on Sept 26, 2016 13:16:02 GMT -5
Em I the only one that isnt stressing at all? If the science is sound and the drug is good and there are no serious documented side effects then people will switch to it. Once people switch and have great results they wont want to go back to injections(cause it makes no sense) thus Mannkind's Afrezza cant fail.
This is an investment and boys shit just got real like July. Its a 3 months old company sales wise(like the supply chain). But kinda not really given all the issues some would says its like 1 month old.
People need to chill. If the science and results are positive this a home run. Once people switch they wont wanna switch back we just gotta ramp it up get people on it.
|
|
|
Post by dictatorsaurus on Sept 26, 2016 13:23:40 GMT -5
The science is not the only recipe for success. You need a solid team to back it up...
|
|
|
Post by silentknight on Sept 26, 2016 13:38:38 GMT -5
You're right. The science is rock solid and the drug is unparalleled in eficacy. Patients rave about it and it's offering diabetics new freedom in ways unimaginable a few years ago.
The problem is that there aren't enough of those patients, yet. Mike C and the team is working on it, but they're also working against a dwindling cash position that will force the company into additional financing options in just a few months.
It's not super dire, yet. It's also not super rosy, yet. Sales are improving as runway is decreasing. At some point, the two variables intersect in a way that will either get us on track for success or forces MNKD to take drastic action to extend said runway.
|
|
Deleted
Deleted Member
Posts: 0
|
Post by Deleted on Sept 26, 2016 14:16:20 GMT -5
When I was deep in this investment and my cousin (he owns his own index fund) was trying to get me to sell when the pps was $4-$5 he put me in touch with a sales manger from a pharma company. My argument at the time was that the drug was too good to fail. The sole reason for this conversation was to explain that he has seen great drugs fail all the time and that it does not guarantee success. I bought into the science but its more then just science
|
|
|
Post by otherottawaguy on Sept 26, 2016 14:27:35 GMT -5
Not getting stressed, getting mad...
|
|
|
Post by figglebird on Sept 26, 2016 14:32:43 GMT -5
No - you are not all alone.
|
|
Deleted
Deleted Member
Posts: 0
|
Post by Deleted on Sept 26, 2016 14:44:08 GMT -5
When I was deep in this investment and my cousin (he owns his own index fund) was trying to get me to sell when the pps was $4-$5 he put me in touch with a sales manger from a pharma company. My argument at the time was that the drug was too good to fail. The sole reason for this conversation was to explain that he has seen great drugs fail all the time and that it does not guarantee success. I bought into the science but its more then just science It's a real shame that it IS more than just science. It shouldn't be that way, but it is.
|
|
|
Post by Cowgirl on Sept 26, 2016 14:45:26 GMT -5
Yeah, a bit as well. They had lots of arrogance for years with Al and his money backing this up. It's all gone now. While I shouldn't be taking pleasure in the price decline as a long it is nice to see Mike C. getting a taste of what investing in Mannkind is all about - share price going down. While I understand "we run the business and the stock price will take care of itself" philosophy the uptake of scripts will not occur fast enough for MNKD. They need more cash which mean diluting. Just nuts. How was this F^&*($5^ up so bad is beyond me.
|
|
|
Post by boytroy88 on Sept 26, 2016 15:05:41 GMT -5
Yeah, a bit as well. They had lots of arrogance for years with Al and his money backing this up. It's all gone now. While I shouldn't be taking pleasure in the price decline as a long it is nice to see Mike C. getting a taste of what investing in Mannkind is all about - share price going down. While I understand "we run the business and the stock price will take care of itself" philosophy the uptake of scripts will not occur fast enough for MNKD. They need more cash which mean diluting. Just nuts. How was this F^&*($5^ up so bad is beyond me. Why would you take pleasure in the decline of sp? Well, I guess that means you are a short....
|
|
|
Post by Cowgirl on Sept 26, 2016 16:13:59 GMT -5
No ...long...just Mike C. getting a taste of what we've all gone through. Maybe it makes it more "real" for them and they try to do something for shareholders to bolster price.
|
|
|
Post by nadathing on Sept 26, 2016 16:29:37 GMT -5
Kinda hard not to stress when the company is running low on money and raising money through dilution will be extremely difficult. It was quite surprising that there was no serious interest from BP in partnering with MNKD for a TS application. The reality is that TS has very little value. It is also surprising that they have not been able to find any partner for the epi application. can't do trials without money. I'd like to be optimistic but there isn't a lot to be optimistic about. I do not foresee good script numbers moving this stock up more than a few penny's. Good science or great science they need cash. I sold 20% of my position today and will buy it back if it drops another .10. I am thoroughly disgusted and depressed over the situation.
|
|
|
Post by als57 on Sept 26, 2016 17:15:30 GMT -5
Has anyone thought that maybe the CEO, Matt Pfeffer, has become incapable of dealing with the circumstance that Wall Street has driven Mannkind into,particularly after he publicly went on the record that launch 2.0 would succeed. I think it only steeled the forces against the company and they shortened the leash that they already had the company on.
|
|
|
Post by mannmade on Sept 26, 2016 17:38:15 GMT -5
Has anyone thought that maybe the CEO, Matt Pfeffer, has become incapable of dealing with the circumstance that Wall Street has driven Mannkind into,particularly after he publicly went on the record that launch 2.0 would succeed. I think it only steeled the forces against the company and they shortened the leash that they already had the company on. Not for a second...
|
|
naykitop
Newbie
Posts: 14
Sentiment: Long
|
Post by naykitop on Sept 26, 2016 19:37:56 GMT -5
At this point, they have pretty much run out of money. When the company has more cash to extend the runway, then we can talk about this launch. It's pretty obvious they'll need to raise capital, unless the ultra-secretive RLS caughs up a significant amount of milestone payments that might extend the runway by another 6-9 months, but I highly doubt they will give $60-90M in the next 2 months (the whole deal was for $112M plus some royalties when commercial stage). So, it looks like we'll be seeing a significant dilution in the coming month or so. I expect the price to level out in the .teens shortly.
|
|
|
Post by mnkdfann on Sept 26, 2016 19:46:54 GMT -5
"I expect the price to level out in the .teens shortly."
I think that (the teens) is unduly pessimistic.
|
|